Interpreting Nonrandomized Evidence for Clinical Decision Making in Cardio-Oncology

JACC CardioOncol. 2023 Jun 20;5(3):329-331. doi: 10.1016/j.jaccao.2023.05.003. eCollection 2023 Jun.

Authors

Safia Chatur¹, Edouard Fu², Muthiah Vaduganathan¹

Affiliations

¹ Division of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
² Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.

No abstract available

Keywords: SGLT2 inhibitor; anthracycline; cardioprotection.

Publication types

Editorial